SARS-CoV-2-specific CD4+ and CD8+ T cell responses can originate from cross-reactive CMV-specific T cells
C. R. Pothast, R. C. Dijkland, M. Thaler…·M. H. Heemskerk
The paper shows that CMV-specific T cells can cross-react with SARS-CoV-2, contributing to pre-existing immunity despite low sequence homology.